Anthony J Duncan, Grayson H Baden, Sandi Zukanovic, Hilla I Sang, Joclyn Seiler Hall
{"title":"Timely Follow-Up After Positive Stool-Based Testing: Evaluating Diagnostic Colonoscopy Delays in Rural and Non-Rural Populations.","authors":"Anthony J Duncan, Grayson H Baden, Sandi Zukanovic, Hilla I Sang, Joclyn Seiler Hall","doi":"10.1177/00031348251385107","DOIUrl":null,"url":null,"abstract":"<p><p>BackgroundColorectal cancer is a leading cause of cancer-related deaths in the United States Hesitancy toward colonoscopy and long wait times have led to increased interest in DNA stool-based testing. Access to timely colonoscopy after positive stool-based tests may be challenging, particularly for rural populations. This study aimed to evaluate the timeliness of diagnostic colonoscopies following positive stool-based tests in rural and non-rural patients.MethodsThis was an observational case-control study of patients aged ≥18 years who had a positive DNA-based stool test and underwent diagnostic colonoscopy between January 2018 and December 2023. Participants were classified as rural or non-rural based on Rural-Urban Commuting Area (RUCA) codes. The primary outcome was the number of days from a positive stool test to diagnostic colonoscopy. Statistical analyses were performed using Wilcoxon rank-sum and Pearson's Chi-squared tests.ResultsOf 1316 patients, 668 (50.8%) were from rural areas. The median time to colonoscopy was 35 days for rural patients and 37 days for non-rural patients (<i>P</i> = .6). There was no significant difference in follow-up times. Rural patients were more likely to undergo colonoscopy at an external facility (25% vs 3.1%, <i>P</i> < .001).ConclusionBoth rural and non-rural patients received timely follow-up colonoscopies after positive stool-based tests, indicating that stool-based testing is an effective and accessible method for CRC screening. This supports the continued use of stool-based DNA testing in reducing the burden on health care systems and enhancing screening accessibility for all patients.</p>","PeriodicalId":7782,"journal":{"name":"American Surgeon","volume":" ","pages":"31348251385107"},"PeriodicalIF":0.9000,"publicationDate":"2025-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Surgeon","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1177/00031348251385107","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"SURGERY","Score":null,"Total":0}
引用次数: 0
Abstract
BackgroundColorectal cancer is a leading cause of cancer-related deaths in the United States Hesitancy toward colonoscopy and long wait times have led to increased interest in DNA stool-based testing. Access to timely colonoscopy after positive stool-based tests may be challenging, particularly for rural populations. This study aimed to evaluate the timeliness of diagnostic colonoscopies following positive stool-based tests in rural and non-rural patients.MethodsThis was an observational case-control study of patients aged ≥18 years who had a positive DNA-based stool test and underwent diagnostic colonoscopy between January 2018 and December 2023. Participants were classified as rural or non-rural based on Rural-Urban Commuting Area (RUCA) codes. The primary outcome was the number of days from a positive stool test to diagnostic colonoscopy. Statistical analyses were performed using Wilcoxon rank-sum and Pearson's Chi-squared tests.ResultsOf 1316 patients, 668 (50.8%) were from rural areas. The median time to colonoscopy was 35 days for rural patients and 37 days for non-rural patients (P = .6). There was no significant difference in follow-up times. Rural patients were more likely to undergo colonoscopy at an external facility (25% vs 3.1%, P < .001).ConclusionBoth rural and non-rural patients received timely follow-up colonoscopies after positive stool-based tests, indicating that stool-based testing is an effective and accessible method for CRC screening. This supports the continued use of stool-based DNA testing in reducing the burden on health care systems and enhancing screening accessibility for all patients.
在美国,结直肠癌是癌症相关死亡的主要原因之一,结肠镜检查的犹豫和漫长的等待时间导致人们对粪便DNA检测的兴趣增加。在粪便检测呈阳性后,获得及时结肠镜检查可能具有挑战性,特别是对农村人口而言。本研究旨在评估农村和非农村患者粪便检测阳性后诊断性结肠镜检查的及时性。方法:这是一项观察性病例对照研究,患者年龄≥18岁,在2018年1月至2023年12月期间进行了基于dna的粪便检测阳性并进行了诊断性结肠镜检查。根据城乡通勤区(RUCA)代码将参与者分为农村和非农村。主要结果是从粪便试验阳性到结肠镜诊断的天数。采用Wilcoxon秩和检验和Pearson卡方检验进行统计分析。结果1316例患者中,农村668例(50.8%);农村患者到结肠镜检查的中位时间为35天,非农村患者为37天(P = .6)。随访时间差异无统计学意义。农村患者更有可能在外部机构接受结肠镜检查(25% vs 3.1%, P < 0.001)。结论农村和非农村患者在粪便检查阳性后均能及时随访结肠镜检查,表明粪便检查是一种有效且可及的CRC筛查方法。这支持继续使用基于粪便的DNA检测,以减轻卫生保健系统的负担,并提高对所有患者的筛查可及性。
期刊介绍:
The American Surgeon is a monthly peer-reviewed publication published by the Southeastern Surgical Congress. Its area of concentration is clinical general surgery, as defined by the content areas of the American Board of Surgery: alimentary tract (including bariatric surgery), abdomen and its contents, breast, skin and soft tissue, endocrine system, solid organ transplantation, pediatric surgery, surgical critical care, surgical oncology (including head and neck surgery), trauma and emergency surgery, and vascular surgery.